Pancreatic ductal adenocarcinoma
Conditions
Interventions
Non-metastatic PDAC:none
control group:none
Metastatic PDAC:none
Sponsors
The First Affiliated Hospital of University of Science and Technology of China
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients: 1.Age =18 years; 2.Pathologically diagnosed as PDAC; 3.Received spectral CT examination within 1 week prior to treatment; 4.Received complete blood count within 1 week prior to treatment; 5.Available surgical or puncture pathological tissue sections. Control group: 1.Age =18 years; 2.Clinically or pathologically diagnosed as non-PDAC patients; 3.Received spectral CT examination within 1 week prior to treatment; 4.Received complete blood count examination within 1 week prior to treatment; 5.Clinically or pathologically diagnosed as non-PDAC patients.
Exclusion criteria
Exclusion criteria: 1.History of other malignant tumors; 2.Previous receipt of anti-PDAC treatments such as radiotherapy or chemotherapy; 3.Poor quality of CT images; 4.Incomplete clinical or pathological data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| metastasis;Metabolic marker;Expression of differential metabolites and the expression levels of related regulatory RNAs and proteins; | — |
Countries
Chian
Contacts
Public ContactWei Wei
The First Affiliated Hospital of University of Science and Technology of China
Outcome results
None listed